Literature DB >> 9192947

Genetic risk factors for chronic obstructive pulmonary disease.

A J Sandford1, T D Weir, P D Paré.   

Abstract

Cigarette smoking is the major risk factor for chronic obstructive pulmonary disease (COPD). However, only a minority of cigarette smokers develop symptomatic disease. Studies of families and twins suggest that genetic factors also contribute to the development of COPD. We present a detailed literature review of the genes which have been investigated as potential risk factors for this disease. The only established genetic risk factor for COPD is homozygosity for the Z allele of the alpha1-antitrypsin gene. Heterozygotes for the Z allele may also be at increased risk. Other mutations affecting the structure of alpha1-antitrypsin or the regulation of gene expression have been identified as risk factors. Genes, including those for alpha1-antichymotrypsin, alpha2-macroglobulin, vitamin D-binding protein and blood group antigens, have also been associated with the development of COPD. Variants of the cystic fibrosis transmembrane regulator gene have been identified as risk factors for disseminated bronchiectasis. The genetic basis to chronic obstructive pulmonary disease has begun to be elucidated and it is likely that several genes will be implicated in the pathogenesis of this disease. The knowledge gained from such studies may also prove relevant to other inflammatory diseases.

Entities:  

Mesh:

Year:  1997        PMID: 9192947     DOI: 10.1183/09031936.97.10061380

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  32 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Chronic airway disease: the infection connection.

Authors:  S B Greenberg; R L Atmar
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

Review 3.  Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  L Fabbri; B Beghé; G Caramori; A Papi; M Saetta
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

4.  [New therapeutic approaches to COPD].

Authors:  M Pfeifer
Journal:  Internist (Berl)       Date:  2004-12       Impact factor: 0.743

Review 5.  New therapies for chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

6.  Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Huan Chen; Lei Zhang; Zhiyi He; Xiaoning Zhong; Jianquan Zhang; Meihua Li; Jing Bai
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

7.  Joint analysis of multiple phenotypes using a clustering linear combination method based on hierarchical clustering.

Authors:  Xueling Li; Shuanglin Zhang; Qiuying Sha
Journal:  Genet Epidemiol       Date:  2019-09-20       Impact factor: 2.135

8.  Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases.

Authors:  Timofey Kalupov; Michèle Brillard-Bourdet; Sébastien Dadé; Hélène Serrano; Julien Wartelle; Nicolas Guyot; Luiz Juliano; Thierry Moreau; Azzaq Belaaouaj; Francis Gauthier
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

Review 9.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 10.  The history of COPD.

Authors:  Thomas L Petty
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.